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Abstract.  Immunohistochemical  methods  were used to 
study the distribution  of basic FGF in the  18-d rat fe- 
tus.  The results reveal a pattern  of widespread yet 
specific staining  that is consistent with the wide distri- 
bution of basic FGE  Immunoreactive  basic FGF is as- 
sociated with mesenchymal  structures,  mesoderm- 
and neuroectoderm-derived  cells,  and their extracel- 
lular matrices.  As an example,  skeletal and  smooth 
muscle cells are strongly positive.  The basement mem- 
brane underlying  the epithelia always contain basic 
FGE  In some tissues (i.e.,  cartilage  and bone) the in- 
tensity of immunostaining  is dependent  on the stage of 
cell differentiation. 
Although  the staining  of tissues is primarily  as- 
sociated with the extracellular  matrix,  there is 
significant  intracellular  staining  in various cell types. 
This is particularly  evident in the endocrine  cells of 
the adrenal  cortex,  testis,  and ovary.  The histochemical 
findings  reported here  support the notion that basic 
FGF has  the characteristics  required  to mediate many 
of the effects of the mesenchyme on cell growth and 
differentiation.  The significance  of these findings  in 
understanding  the role of basic FGF in regulating  cell 
proliferation  and differentiation  is discussed. 
B 
ASIC fibroblast growth factor (FGF) 1 is a pluripoten- 
tial growth factor that is mitogenic for various types 
of mesoderm-  and  neuroectoderm-derived  cells  in 
culture (6, 23, 24). In various in vivo models, basic FGF is 
multifunctional. As an example, it is a potent angiogenic fac- 
tor that can also induce the formation of mesenchyme (16, 
30), yet it represses terminal differentiation of skeletal mus- 
cle (10).  It has also been associated with such processes as 
wound healing  (18, 37, 42),  normal  reproductive  function 
(21)$  fetal (32)  and embryonic (38,  39,  43) development, 
and in tumorigenesis (16).  The high concentrations of basic 
FGF that are found in the brain and the fact that it can in- 
crease the survival of peripheral and central neurons in vivo 
and in vitro, support the notion that it is also a neurotrophic 
factor (3,  35, 4 ! , 48, 50). 
Although basic FGF can be purified from different organs 
and tissues, its distribution in these tissues is not known. The 
characterization of the protein and the cloning of its mRNA 
from bovine (1, 14), ovine (45), human (2, 9), rat (44), and 
frog (30) eDNA libraries has revealed that the sequence of 
basic FGF is highly conserved between species and permit- 
ted the direct study of the gene transcription and translation. 
It is synthesized by almost all of its target cells (including 
1. Abbreviations  used in this paper:  FGF,  fibroblast growth factor;  TGF, 
transforming growth  factor. 
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A. J. W. Hsueh, unpublished observations. 
some tumor cells) when they are grown in culture (5). Yet, 
while the expression of basic FGF is high in the adult brain, 
in peripheral tissues its mRNA is low to undetectable (13, 34, 
44). This is particularly remarkable when coupled to the fact 
that  it is present  in  sufficiently high  concentrations  to be 
purified and characterized from many peripheral tissues in- 
eluding pituitary, cartilage,  bone, placenta,  corpus luteum, 
kidney, adrenal,  heart, muscle, eye, and retina (5, 24). Be- 
cause of this  wide distribution,  the virtual  absence of its 
mRNA, and its high affinity for heparin, several investigators 
have proposed that basic FGF is stored and stabilized in the 
extracellular matrix  (4, 5,  17, 49). 
Several studies have now shown that the gene for basic 
FGF is expressed in early embryonic development, and have 
suggested that the growth factor may play an important role 
in tissue growth and differentiation (26, 30--32).  Because the 
expression of basic FGF during embryonic development oc- 
curs  at a  time  when there is extensive tissue growth  and 
remodeling, the conditions are ideal for its incorporation into 
the basement membrane.  In the  study described here,  we 
have localized basic FGF to the basement membrane in many 
diverse tissues of the 18-d fetal rat. At this stage, tissues are 
almost completely differentiated but there is extensive re- 
modeling in progress.  The observation that the appearance 
of basic FGF in the extracellular matrix is dependent on the 
stage of tissue differentiation may help determine its physio- 
logical function in normal mammalian development and em- 
phasizes the need for further studies on the distribution of 
basic FGF in the developing embryo. 
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1Issue Preparation 
18-d-old  Sprague-Dawley  rat fetuses  were collected  from pregnant rats, 
fixed in Bouin's solution, dehydrated through a graded series of ethanol, and 
embedded  in  paraffin.  8-#m  sagital  sections  were  deparaffinized  and 
hydrated.  Endogenous peroxidase activity was quenched by incubating the 
sections for 30 min in 0.3 % hydrogen peroxide in absolute methanol at room 
temperature.  To facilitate penetration of the antibody into the tissue, the sec- 
tions were then washed in PBS and treated with 1 mg/ml of hyaluronidase 
(type V; Sigma Chemical Co., St. Louis, MO) buffered at pH 5.5 with 0.1 M 
sodium acetate  containing 0.15 M NaC1, for 30 min at 37°C.  Unless de- 
scribed otherwise, each step of the staining procedure was performed at 
room temperature. 
Antibodies 
Polyclonal antibodies were raised against the 1-24 synthetic fragment of bo- 
vine basic FGF (1-146).  These antibodies detect basic FGF and do not 
recognize (<1%) acidic FGE  Although their cross-reactivity with int-2, 
hst/ks, FGF-5,  and FGF-6 is not known,  there is low sequence homology 
in the area corresponding to the peptide  antigen sequence used.  IgG frac- 
tions  were  prepared  by  ammonium  sulfate  precipitation  (30%),  were 
purified by passage over a protein A-Sepharose column and used in the 
studies reported here. In control studies,  the IgG (2.5 #g/ml of IgG) used 
was preincubated with Affigel 10 alone or with Affigel 10 that had been cou- 
pled with recombinant basic FGF (400/~g/ml). The Affigel was removed 
by centrifugation and the supernatants were used.  These controls were 
confirmed by staining in the presence (100/zg/ml) of the peptide fragment 
FGF(1-24)  or  by  removing  the  anti-FGF  IgG  by  passage  through an 
Affigel-FGF affinity column. Both of these procedures failed to stain the 
tissue sections (not shown).  Basic FGF was coupled to the Affigel 10 ac- 
cording to manufacturer (Bio-Rad Laboratories,  Richmond, CA) specifica- 
tions. Identical staining was observed with IgG prepared from a polyclonal 
antibody raised in rabbits against intact human recombinant basic FGF (8) 
(not shown). 
Immunohistochemistry 
The tissue sections were incubated in 1.5% goat serum (Vector Laborato- 
ries, Inc,, Burlingame,  CA) for 30 min to reduce nonspecific  staining. The 
sections were subsequently incubated overnight (20 h) at 4"C with the pro- 
tein A-purified antibodies (2.5  t~g/ml) diluted in PBS supplemented with 
0.3% Triton and 5% BSA. The sections were then treated with a 1:200 dilu- 
tion of biotinylated goat anti-rabbit IgG (Vector Laboratories, Inc.) for 1 h, 
followed by a 30-rain incubation with a biotin-avidin-peroxidase complex 
(Vector Laboratories, Inc.). Finally, the sections  were treated for 5 min in 
0.5 mg/ml of diaminobenzidine (Sigma Chemical Co.) prepared in 10 mM 
TBS, pH 7.6, and containing 0.01% hydrogen peroxide.  All steps were sepa- 
rated by buffer washes consisting of PBS-0.3%  Triton.  The sections were 
counterstained in Harris hematoxylin, dehydrated,  cleared, and mounted. 
In control experiments,  the antibodies were replaced  with either (a) BSA, 
(b) normal rabbit serum, (c) Affigel 10-treated IgG,  (d) Affigel 10/FGF- 
treated IgG, (e) IgG prepared from the flow through of a Affigel-basic FGF 
immunoaflinity column, or (f) IgG presorbed with FGF (1-24).  Some of 
the tissue sections were also pretreated with 0.15 M NaCI,  1 M NaCI,  or 
2 M NaC1 in PBS for 5 or 15 min before the immunostaining to selectively 
remove the basic FGF from the extracellular matrix of tissues. 
Results 
Cross Section of the Entire 18-d Rat Fetus 
Staining of  the 18-d rat fetus with the protein A-purified anti- 
body to basic FGF revealed a  widespread distribution of 
staining in several though not all tissues (Fig. 1 A). Absorp- 
tion of the antibody to Affigel-basic FGF beads abolished 
virtually all staining (Fig.  1 B). A total absence of staining 
was also obtained by passing the antibody through an Affigel- 
FGF immunoaffinity column or by pre- or coincubating the 
antisera with the peptide antigen basic FGF(1-24)NH2  (not 
shown). When the anti-basic FGF was replaced by BSA or 
normal rabbit serum, there was also no staining observed 
(not shown). As expected, when the anti-basic FGF antise- 
rum was preincubated with uncoupled Affigel 10 only, there 
was no blocking of the staining. On this basis we concluded 
that the antisera is recognizing a basic FGF-like antigen in 
the tissue sections. It is important to note that a combination 
of high background and extensive undisplaceable staining of 
the skin, gut, and ganglionic neurons precluded the use of 
unpurified antisera (not shown). 
As shown in Fig.  1 A, there is a clear, widespread, and 
diffuse pattern of staining that is not exclusively localized in 
any one tissue.  Mesodermal-derived tissues are positively 
stained and the staining is more intense where there is jux- 
taposition with the epithelium. The epithelial cells in each 
of the different tissues and the blood ceils are devoid of any 
basic FGE It is the mesenchyme underneath epithelial tis- 
sues (i.e., skin, buccal tract, salivary gland, gut, kidney, and 
lung in Fig. 2) that shows intense positive staining. This pat- 
tern of staining is associated for the most part with the ex- 
tracellular matrix but can also be associated with the cell it- 
self  (Fig.  2).  All  basement  membranes  underlying  the 
epithelial  cells  of the  digestive tract,  skin,  lung,  kidney, 
Miillerian and Wolffian ducts, salivary glands, pancreas, sex 
cords, and sebaceous glands are strongly positive, but the ep- 
ithelial cells themselves are negative (see Figs. 2, 5, 7, and 
8).  The endothelial ceils from capillaries and large vessels 
show a strong staining (Figs. 2 A and 3, C and D). In the brain 
and spinal cord there is also widespread staining. In all in- 
stances, however, there is an absence of staining when per- 
formed with ligand affinity-absorbed antibody (see Fig. 9, 
B-E). 
Muscle 
Among mesoderm-derived tissues, skeletal muscle (Fig. 3, 
A and B) and smooth muscle associated with the digestive 
tract (Fig. 2 D) and arteries (Fig. 3 D) are strongly positive. 
Staining can be clearly seen in transversal as well as in lon- 
gitudinal sections. The staining is associated with intracellu- 
lar myofibers as well as with the surrounding connective tis- 
sue (Fig. 3, A and B). In the heart (Fig. 3 C), the myofibers 
show a  very low signal, but the small vessels that supply 
the ventricular muscular fibers are distinctly positive. The 
smooth muscle cells of the walls of the large vessels show 
intense staining (Fig. 3 D). 
Cartilage and Bone 
In cartilage, the pattern of staining changes according to the 
stage of  differentiation (Fig. 4). As an example, chondrocytes 
in early stages of differentiation are clearly positive (Fig. 4 
A),  but before ossification, when they are turning hyper- 
Figure 1. Sagital section of an 18-d-old rat fetus. Sections were stained as described in the text with protein A-purified anti-basic FGF 
(A) and a preparation of antibody specifically depleted of anti-FGF IgG by FGF affinity chromatography (B). Bars, 1 mm. 
Gonzalez et al. Localization  of Basic FGF  755 Figure 2. Localization of basic FGF in epithelial tissues and their basement membranes. The basement membrane (arrows) underlying 
different epithelium and the associated cell-dense mesenchyme (m) is consistently stained in various tissue sections. (A) Skin; (B) buccal 
tract; (C) salivary gland; (D) digestive tract; (E) kidney; (F) lung. Stratum granulosum (sg), stratum basale (*), palate (p), and tongue 
(t) are indicated. Bars, 50 ~m. 
trophic, immunoreactive basic FGF is localized in the carti- 
lage matrix (Fig. 4 B).  This distribution is clearly visible 
during the process of ossification where the matrix is strongly 
positive (Fig. 4  C). The centers of ossification (which are 
characterized by calcification of the hyaline matrix, regres- 
sive hypertrophia of the chondrocytes, and by active capil- 
lary growth), contain intense staining for basic FGF in both 
the calcified matrix and inside the osteoblasts (Fig. 4/9). The 
absence of staining in control studies can be established in 
all instances of chondrocyte differentiation (see Fig. 9, F-I). 
Skin, Hair Follicles,  and Teeth 
The specific staining in skin is associated with the compact 
cells of the mesenchyme and with basement membranes 
(Fig.  5  A).  Strong  staining  is  observed  in  the  stratum 
granulosum and it appears exclusively extracellular (Fig. 5 
B). The stratum basale is devoid of staining but the mesen- 
chymal cells of the dermis show an intense positive reaction 
that is stronger in cell-dense areas (Fig. 5, B and C). In the 
hair follicles and in the forming teeth, basic FGF is also 
found in the compact mesenchyme. As in other tissues, the 
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muscle. The striated and smooth 
muscle and the surrounding loose 
connective  tissue  contain  basic 
FGF immunoreactivity. (A) Lon- 
gitudinal section of a striated mus- 
cle. (B) Transversal and longitu- 
dinal sections of striated muscle. 
(C) In the heart, the capillaries 
that irrigate the ventricular mus- 
cular fibers are strongly positive 
but the cardiac fibers show only 
low staining. (D) The medial layer 
of  arteries which are mainly com- 
posed of smooth muscle cells are 
strongly positive. Bars, 25 #m. 
capillary  endotheliurn  and  the  basement  membrane  as- 
sociated with the epidermis contain basic FGF immunoreac- 
tivity. 
Central and Peripheral  Nervous System 
On the whole, the brain shows widely distributed, although 
not homogeneous, staining for basic FGF (Fig. 6 A). Some 
areas (such as the telencephalon) show a higher intensity of 
staining in areas that are neuron rich. The staining is also 
specific as judged by the failure of ligand affinity-absorbed 
antibody to show a reaction (Fig. 9 A). In the diencephalon 
and mesencephalon, however, the staining is associated with 
fibers (Fig. 6 B). It is similar in the spinal cord, which also 
shows a diffuse staining pattern that is stronger around cells 
associated with the capillary endothelium (Fig. 6 C). In the 
paravertebral ganglions (Fig. 6 D), the ganglionic cells show 
low levels of staining  which are unremarkable,  especially 
when compared to peripheral nerves. The peripheral nerves 
entering  the  ganglia  show  an  intense  staining  that  is  as- 
sociated with the nerve fibers, fibroblasts, endothelial cells, 
and the extracellular matrix. Unlike these areas of the ner- 
vous system, the choroid plexus shows the same pattern of 
staining that is seen in most other tissues (Fig. 6 A). The im- 
munoreactive basic FGF is associated with loose connective 
tissue and the capillary bed, but not with epithelial cells. The 
meninges are also strongly positive (Fig.  6 A). 
Endocrine Tissues 
In the testis (Fig. 7, A and B), ovary (Fig. 7, C and D), and 
adrenal cortex (Fig. 8 A), the steroidogenic cells all show the 
presence of immunoreactive basic  FGE  The extracellular 
matrix that is associated with the loose connective tissue, the 
capillary endothelial cells, and their basement membranes 
are also stained. In the testis, the sex cords are completely 
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different stages of cartilage differ- 
entiation.  (A) Chondrocytes (ar- 
rows) and hyaline matrix show a 
positive  staining for  anti-basic 
FGE  The perichondrium  (p)  is 
also highly stained. As shown in 
B in the early stages of ossifica- 
tion, the staining is mainly local- 
ized in the perichondrium (p) and 
the hyaline matrix is only slightly 
positive. At later stages of ossifi- 
cation (C), the hypertrophic  chon- 
drocytes (arrows) are almost neg- 
ative  and  the  hyaline matrix  is 
positive. Finally when the hyaline 
matrix is ossified (D), basic FGF 
immunoreactivity is observed in- 
side the osteoblasts (arrows) and 
the matrix shows a strong stain- 
ing. Bar, 50/zm. 
negative but are underlined by a strongly positive basement 
membrane (Fig. 7 A). At high magnification (Fig. 7 B), the 
fibroblast-like cells of the interstitium only show moderate 
immunoreactivity whereas the basement membrane and the 
peritubular cells are more strongly stained.  In the Leydig 
cells of the testis, the staining is both intraceUular and cell 
surface associated (Fig. 7 B). The tunica albuginea and the 
interstitium show only a moderate positive reaction. In the 
ovary, the stroma,  which is not yet fully differentiated, is 
stained (Fig. 7, C and D). The positive staining in the adrenal 
appears  to  be  restricted  to  the  fasciculata and  reticularis 
layers of  the cortex (Fig. 8 A). The glomerulosa and the adre- 
nal capsule contain no basic FGE When the tissue sections 
are incubated with the antibodies depleted of anti-IgGs by 
affinity chromatography, there is no staining (Fig.  8 B). 
There is significant basic FGF associated with the base- 
ment membrane underlying the endocrine cells of the differ- 
entiating pituitary gland (Fig.  8  C).  With the exception of 
some cells, the pars nervosa, intermedia, and pars distalis all 
contain basic FGE 
Basic FGF is Located in the Extracellular Matrix 
Tissue sections were incubated with PBS containing 2  M 
NaCI for 15 min to differentiate  between extracellular and in- 
tracelhlar staining and remove any endogenous basic FGF 
bound to glycosaminoglycans. Under these conditions, the 
presence of  basic FGF disappeared from the basement mem- 
brane, but intracellular staining was unaffected (Fig.  8 D). 
Washing the sections with lower salt concentrations (0.15 M 
NaCI in PBS) had no effect (Fig. 8 D). As expected, when 
the  tissues  are  incubated  with  IgGs  that  are  specifically 
The Journal,of  Cell Biology.  Volume 110, 1990  758 Figure 5. Localization of basic FGF in the skin. The specific staining is associated with cells of the compact mesenchyme (m), basement 
membrane (arrows), and the capillary endothelium (A-C). In the skin (A and B), the strong staining seen in the stratum granulosum (sg) 
is exclusively extracellular. The stratum basale (*) is negative. A and B also show staining surrounding the hair follicles and C shows a 
tooth in formation. Blood vessels (bv), stratum granulosum (sg), stratum basale (*), tooth (t), and basement membrane (arrows) are indi- 
cated. Bars, 50/~m. 
depleted of anti-basic FGF antibodies, there is no staining 
(Fig.  8 E). 
1issues Lacking Basic FGF 
The  fetal  liver  shows  the  lowest  staining  for basic  FGF 
among all of the tissues studied.  Only the capsule and the 
vessels perfusing the organ reveal the presence of basic FGF 
(data  not  shown).  There exist  several  cell  types that  are 
clearly devoid of immunoreactive basic FGF in the 18-d fe- 
tus. In each instance, they are distributed in many tissues. As 
an example, epithelial cells appear to be negative (Figs. 2-5). 
Similarly, cells of the adrenal capsule and zona glomerulosa 
appear devoid of immunoreactive basic FGF (Fig.  8 A). 
Specificity of Staining 
Tissue sections that have been shown to contain FGF by im- 
munohistochemical analyses were all tested for the specifi- 
city of the staining (Fig. 9). In each instance, there is an ab- 
sence of staining when the sections are examined using an 
IgG preparation that is depleted of anti-basic FGF antibod- 
ies.  Similarly, there is no staining when the anti-FGFs are 
coincubated with the antigen peptide FGF (1-24). 
Discussion 
The results presented here demonstrate that basic FGF is as- 
sociated with tissues of mesodermal and ectodermal origin 
and is predominantly localized in areas where the epithelium 
and mesenchyme are in juxtaposition. In the 18-d-old rat fe- 
tus, the distribution of basic FGF in some tissues (such as 
cartilage) is related to the stage of differentiation. Specifical- 
ly, the presence of  basic FGF in compact early chondrocytes, 
and its absence later in the hypertrophic ones, supports the 
notion that it is released into the matrix and plays a role in 
regulating  chrondrocyte function before ossification  (19). 
These data thus correlate well with the reported mitogenic 
activity of the matrix of bone and cartilage (25, 49), and the 
fact that ossification is accompanied by an intense burst of 
angiogenesis. 
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sic FGF in the nervous system. 
(A)  Low  magnification  of  the 
brain.  (B)  Mesencephalon.  (C) 
Spinal  cord.  (D)  Paravertebral 
ganglion.  In  the  telencephalon 
(0,  an homogeneous staining is 
seen in high density neuron peri- 
karia  areas. The meninges (ar- 
rowheads)  are very positive. The 
ehoroid plexus (cp) shows a posi- 
tive staining that is associated  with 
loose  connective tissue  but  not 
with epithelial cells. The mesen- 
cephalon (B) and the spinal cord 
(C)  show a  different pattern  of 
staining. The peripheral  nerves (D) 
that are entering a paravertebral 
ganglion  show strong  staining 
compared to the ganglionic neu- 
rons. Telencephalon (t), choroid 
plexus  (cp),  and  meninges (ar- 
rows) are indicated. Bars: (A) 100 
#m; (B-D) 50 #m. 
In the brain, as well as in the spinal cord, basic FGF is 
widely distributed but is clearly more concentrated in en- 
dothelial cells. Staining in the telencephalon correlates with 
areas where there is a high density of neuronal cell bodies. 
In  contrast,  in  the  diencephaion  and  mesencephaion the 
staining is associated with fiber-rich areas. Staining of basic 
FGF in the fetal brain is consistent with many of its potent 
effects on central nervous system--derived neurons and glia 
(3, 5, 35, 41, 48, 50). The intense staining in the peripheral 
nervous system contrasts with the low staining of paraver- 
tebral  ganglionic cells.  Several investigators have demon- 
strated that basic FGF enhances peripheral nerve regenera- 
tion and that it promotes the survival, axonal bridging, and 
remodeling oftransected nerve stumps (references 11, 18, 36, 
51; Cuevas, P., E  Carceller, A. Baird, and R. Guillemin, un- 
published results; Cuevas, P., E  Carceller, A. Esteban, A. 
Baird,  and R.  Guillemin, unpublished results).  It is obvi- 
ously difficult to specify the actual intra- or extracellular lo- 
cation of basic FGF without a further analysis using double 
staining and/or immuncelectron microscopy. The results at 
18 d of gestation are clearly compatible with atrophic func- 
tion for endogenous basic FGF and may explain, at least in 
part, the regenerative capacity of this tissue. Further studies 
at different stages of development are in progress and will 
help to elucidate the role of basic FGF in the morphogenesis 
of central and peripheral nervous systems. 
The localization of basic FGF in the adrenal cortex, in the 
Leydig cells of the developing testes, and in the stroma of the 
ovary is compatible with its reported effects on cells derived 
from the adrenal  (20,  28),  testis  (15),  and ovary.  2 It was, 
thus, of particular interest to note that the basic FGF that has 
been localized in the adrenal is not associated with the cap- 
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FGF  in  gonads. (,4  and  B)  In 
the  testis,  Leydig cells  (arrows) 
and the basement membrane are 
strongly positive; the interstitium 
and tunica albuginea show mod- 
erate positive staining. At higher 
magnification (B), the absence of 
staining over the sex cords and the 
moderate staining over the non- 
differentiated fibrocyte-like cells 
of the interstitium is clear. There 
is also intense staining over the 
basement membrane (arrows) and 
of  the peritubular cells. A similar 
pattern  of staining  is  observed 
in  the  ovary where  the  stroma 
and the basement membrane are 
strongly positive when observed 
at low (C) and high (D) magnifi- 
cation.  Interstitium  (i),  stroma 
(s), sex cords (sc), tunica albuginaa 
(a), basement membrane (arrow- 
heads), and Leydig cells (arrows) 
are indicated. Bars,  100 #m. 
sule and glomerulosa zone of the cortex, which are the active 
sites of  cell proliferation and aldosterone production, respec- 
tively, but with its target cells, the cells of  the zona fasciculata 
and reticularis which produce corticosterone. However, just 
as the basic FGF stored in the basement membrane of the sex 
cords may play a role in the regulation of  germ cell prolifera- 
tion (and as such, participate in sexual differentiation), fur- 
ther studies are required to confirm the physiological func- 
tion of basic FGF in endocrine tissues. In particular, it will 
be important to establish the distribution of basic FGF in 
adult tissues. Clearly, however, its wide distribution is con- 
sistent with the notion that basic FGF is a pluripotent, mul- 
ti  functional factor. As such its activities in each tissue are 
most  likely autonomous  and  restricted  to  the  local  envi- 
ronment. 
Several lines of evidence suggest that growth factors and 
in particular the acidic and basic FGFs are involved in the 
regulation of growth and differentiation of mammalian em- 
bryos (30, 32, 46). Growth factors are mitogenic for a wide 
range of stem cell types, and they can induce differentiation 
in various cells, including many embryonic cells in vitro. Ex- 
tracts of rat embryos can stimulate fibroblast proliferation in 
vitro in a manner similar to that of purified basic FGF (27). 
Moreover, recent evidence has  established  that  FGFs are 
transiently expressed in the kidneys of mouse embryos (39), 
and are detectable in the fetal brain (40) and in the developing 
chick  embryo  (33,  43).  In  this  latter  instance,  immuno- 
histochemical studies have localized basic FGF in the muscle 
of the developing chick (29). Basic FGF has also been de- 
tected, isolated, and recently characterized from the human 
placenta (22, 47), and specific antisera can inhibit fertility 
of rats and rabbits (Baird, A., M. Ong, and A. M. Gonzalez, 
Gonzalez et al. Localization of Basic FGF  761 Figure 8. Staining of basic FGF in the adrenal and pituitary gland. The positive staining for basic FGF in the fetal adrenal (A) is restricted 
to the fasciculata and reticularis layers of cells. The zona glomerulosa and the adrenal capsule are completely negative. As shown in B, 
no staining of the adrenal is observed using the preparation depleted of anti-basic  FGF by affinity chromatography, c, capsule; g, zona 
glomerulosa; fr, zona fasciculata-reticularis. In the pituitary (C), there is a strong staining in the basement membrane surrounding the 
endocrine cells. Some cells of the anterior pituitary are also positive. When the sections arc preincubated with buffer containing 2 M NaC1 
(D), the extracellular staining disappears. No staining is observed with the affinity-depleted  preparation (E). Pars distalis (pd), pars interme- 
dia (pi), and pars nervosa (pn) are indicated. Bars: (A and B) 100 #m;  (C-E) 50 gm. 
unpublished observations). The observation that basic FGF 
stimulates the growth of transplanted rat embryos, whereas 
a specific antibody raised against basic FGF induces growth 
retardation and underdevelopment of all tissues of endoder- 
mal and mesodermal origin, strongly supports a role for ba- 
sic FGF in fetal development (32). 
There is also strong evidence that basic  FGF promotes 
growth  and/or  affects differentiation in  adult  vertebrates. 
FGFs are powerful angiogenic factors found in normal and 
tumor tissues (16). They promote wound healing in rodents, 
and lens and limb regeneration in amphibians (references 18, 
37, 42; Cuevas, E, E  Carceller, A. Esteban, A. Baird, and 
R. Guillemin, unpublished observations). The fact that basic 
FGF is present at the level of the basement membrane in the 
fetus (as shown here) suggests that it is released from the cell 
and stored in this structure during development. Whether or 
not it is this same basic FGF that is later localized in the adult 
matrix (12) remains to be established. Because basic FGF 
exhibits a very high affinity for heparin in vitro, this localiza- 
tion of basic FGF is not surprising when one considers the 
presence of  heparan sulfated proteoglycans in many extracel- 
lular matrices. 
The mechanism through which basic FGF gets outside the 
cells is not known for it lacks a classical signal sequence to 
mediate secretion (1, 2, 44). During development, the base- 
ment membrane and other structures in the extracellular ma- 
trix undergo very extensive remodeling and, as such, during 
this time basic FGF could be locally released. By virtue of 
its association with the extracellular matrix, basic FGF may 
participate in regulating tissue growth and differentiation. 
This could suggest that the extracellular matrix is regulating 
FGF activity (4, 5, 17). In the adult, basic FGF stored in this 
The Journal of Cell Biology, Volume  110, 1990  762 Figure 9. Specificity of basic FGF staining. Tissue sections were incubated as described in Materials and Methods with an IgG preparation 
that was depleted of anti-basic  FGF antibodies using Attigel 10-basic FGF. In sections of (A) brain,  (B) lung, (C) salivary gland, (D) 
gut, (E) testis, and (F-I) cartilage, there is an absence of staining. In the latter instance, there is no staining in (F) hyaline cartilage, (G) 
matrix and hypertrophic chondrocytes, (H) ossification centers and (I) during matrix calcification and regression of chondrocytes. Bars, 
50 #m. 
structure could then be released to participate in tissue re- 
pair, and maintenance of differentiated function. 
The polyclonal antibody used  in  this  study  was  raised 
against a  1-24 synthetic fragment of bovine basic FGF(1- 
146), thus decreasing the possibility of cross-reactivity with 
other members  of the  basic  FGF  family.  This antiserum 
reacts with human basic FGF and shows a  10% cross-reac- 
tivity with rat basic FGF,  but >0.1%  cross-reactivity with 
acidic FGF (data not shown). Because the sequences of  many 
of the rat-derived proteins are not known and with the large 
number of members of the FGF family, we cannot exclude 
the possibility that the staining pattern is exclusively related 
to basic FGE Western blotting analysis has shown that this 
antibody recognizes all of the molecular forms of rat basic 
FGF that have been identified so far (not shown). It is impor- 
tant to note that the staining pattern that is reported here has 
also been seen with an antibody raised against intact recom- 
binant basic FGE Furthermore, the pattern of staining with 
other antisera, such as antifibronectin and anti-transforming 
growth factors/51 and 2 (TGFB1 and 2), is quite different (not 
shown). 
The present study, while descriptive, clearly identifies ba- 
sic FGF in many cellular structures. The results do not rule 
out the possibility of interaction of basic  FGF with other 
growth factors in developmental processes. As an example, 
Kimelman and Kirschner (30) have shown that TGF/5 can 
modulate the effect  of basic FGF during development. Clear- 
ly, it will be important to compare the findings reported here 
to the distribution of other growth factors during fetal devel- 
opment. To this end, the localization of TGFB1 in the mouse 
embryo was recently described (26), and it is interesting to 
note that in spite of the fact that many mesoderm-derived tis- 
Gonzalez et al. Localization of Basic FGF  763 sues  contain TGF31,  the precise pattern  of distribution  is 
significantly different from that of basic FGE As an example, 
TGFB, while extracellular,  is not localized in the basement 
membrane. Because embryonic development most likely re- 
lies  on  local  time  and  concentration-dependent  effects of 
growth factors, comparative analyses of growth factor distri- 
bution will require an assessment of their cellular localiza- 
tion, quantitation,  and time course of expression. The results 
presented here establish the presence of basic FGF adjacent 
to cells that in vitro and in vivo studies predicted were the 
target  of  its  potential  physiological  function.  It  remains 
necessary  to  establish,  however,  that  basic  FGF  actually 
plays  a physiological function at each of these sites. 
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